
1. curr opin drug discov devel. 2004 mar;7(2):228-32.

toward vaccines cervical cancer.

jansen ku(1).

author information: 
(1)merck & co inc, west point, pa 19486, usa. kathrin_jansen@merck.com

cervical cancer pre-cancerous lesions genital tract major threat
to health women worldwide. introduction screening tests detect
cervical cancer precursor lesions reduced cervical cancer rates the
developed world, developing countries. approximately 80% the
470,000 cervical cancer cases diagnosed worldwide year occur developing
countries. despite advances treatment cervical cancer, half the
women disease die. last 20 years, several lines of
scientific investigation identified oncogenic human papillomaviruses as
etiological agents cervical cancer, led development of
prophylactic vaccines disease.


pmid: 15603257  [indexed medline]

